Cidara Therapeutics Inc

0.00 (0.00%)
7:59:47 PM EDT: $1.02 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)92.06M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$8.14 Million
Adjusted EPS-$0.15
See more estimates
10-Day MA$1.03
50-Day MA$0.96
200-Day MA$1.14
See more pivots

Cidara Therapeutics Inc Stock, NASDAQ:CDTX

6310 Nancy Ridge Drive, Suite 101, San Diego, California 92121
United States of America
Phone: +1.858.752.6170
Number of Employees: 73


Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.